Lukas Stolz

Interventional cardiologist / Cardiologist
Klinikum der Universität München - Munich, Germany

Latest contributions

Mitral abstracts session

22 May 2025 – From EuroPCR 2025

Examine critical mitral valve research through a series of abstracts focusing on mitral TEER outcomes. Topics include the impact of mitral valve complexity, prognostic significance of right atrial pressure, comparative analysis of degenerative versus functional mitral regurgitation, and validation of risk scores, providing valuable insights for...

Mitral abstracts session

Right heart catheterisation and CT scan for the assessment of A-V valve treated percutaneously

21 May 2025 – From EuroPCR 2025

This session evaluates right heart catheterisation and cardiac CT imaging in the assessment of percutaneously treated atrioventricular valves. Explore clinical outcomes, invasive physiology characterization, annular remodeling, and pulmonary hypertension impact on mitral and tricuspid valve interventions.

Right heart catheterisation and CT scan for the assessment of A-V valve treated percutaneously

How to select appropriate cardiovascular intervention for a patient with tricuspid regurgitation?

21 May 2025 – From EuroPCR 2025

Learn how to select appropriate cardiovascular interventions for tricuspid regurgitation patients by considering comorbidities, anatomical factors influencing procedural success, and imaging criteria for device selection. The session includes patient vignettes to illustrate decision-making pathways.

How to select appropriate cardiovascular intervention for a patient with tricuspid regurgitation?

Recurrent and residual tricuspid regurgitation after transcatheter repair - Assessment and management

26 Nov 2024 – From PCR London Valves 2024

Join us as we delve into the critical topic of recurrent and residual tricuspid regurgitation after transcatheter repair. Gain valuable insights on how to avoid these complications, learn to assess the underlying mechanisms and severity, and explore the latest options for interventional treatment. This session, developed...

Recurrent and residual TR after transcatheter repair - Assessment and management

Predictors and clinical relevance of residual tricuspid regurgitation after transcatheter repair

29 Apr 2025 – From PCR London Valves 2024

Curious about the latest advancements in transcatheter tricuspid valve interventions? Don't miss this discussion between Philipp Lurz and Lukas Stolz as they delve into the topic of residual tricuspid regurgitation after transcatheter repair—a challenge that still needs improvement despite significant progress.

This interview was filmed at PCR...

Predictors and clinical relevance of residual tricuspid regurgitation after transcatheter repair

Breaking barriers in tricuspid valve repair

25 Nov 2024 – From PCR London Valves 2024

What’s driving the future of transcatheter tricuspid valve repair (TTVR)? Dive into the latest breakthroughs with this video!

Gain insights into real-world outcomes from TTVR registries, uncover key findings from the TriCLASP study, explore how TriClip TEER reshapes the right heart, learn how pulmonary hypertension influences TTVR...

Breaking barriers in tricuspid valve repair

Featured research - Aortic valve (Part 3)

24 Nov 2024 – From PCR London Valves 2024

Featured research - Aortic valve (Part 3)

Clinical outcomes of transcatheter mitral and tricuspid valve repair and replacement

15 May 2024 – From EuroPCR 2024

Clinical outcomes of transcatheter mitral and tricuspid valve repair and replacement

Tricuspid TEER - Part 2

20 Nov 2023 – From PCR London Valves 2023

Key questions in tricuspid valve intervention - How does the role of the right heart and pulmonary vasculature influence patient selection?

19 Nov 2023 – From PCR London Valves 2023

Explore insights from an 86-year-old female patient's case with TAVR since end-2022 who presented with permanent AF, moderate MR and TR regurgitation, and learn more about right heart catheterisation for patient selection, CT and CMR in tricuspid interventions, criteria for atrial secondary TR, and more!

How does the role of the right heart and pulmonary vasculature influence patient selection?

The Top Late-Breaking Trials: TRISCEND II, TRILUMINATE at 3 years, EuroSMR score, CLASP IID, OPERA-TAVI...

19 Nov 2023 – From PCR London Valves 2023

Discover the top late-breaking trials which were presented during PCR London Valves 2023:

  • TRISCEND II: A randomised trial of transcatheter tricuspid valve replacement vs medical therapy
  • Percutaneous edge-to-edge repair for tricuspid regurgitation: TRILUMINATE trial three-year outcomes
  • Transcatheter mitral valve-in-valve vs. redo surgical replacement for degenerated bioprostheses
  • Artificial intelligence derived risk...
PCR London Valves 2023 Top Late-Breaking Trials

Mitral and tricuspid valve intervention : new devices and clinical outcomes

17 May 2023 – From EuroPCR 2023

Need a reminder on this session about the new devices and clinical outcomes in mitral and tricuspid valve intervention? Take a look at these slides and review the essential in a glance.

Mitral and tricuspid valve intervention

Patient selection for tricuspid valve interventions

28 Nov 2022 – From PCR London Valves 2022

Consult this session to learn more about the anatomical assessment of candidates for transcatheter tricuspid valve interventions, to understand the importance of detailed haemodynamic assessment in patients with severe tricuspid regurgitation and to discuss the predictors of clinical outcome after these interventions.

Patient selection for tricuspid valve interventions

Imaging for mitral valve interventions

28 Nov 2022 – From PCR London Valves 2022

Thanks to this PCR LV 2022 session, find out more about outcome of patients undergoing transcatheter edge-to-edge mitral valve repair with HFpEF diagnosis.

Imaging for mitral valve interventions